Pictet Asset Management Sa Neuro Pace Inc Transaction History

Pictet Asset Management Sa

  • $83.4 Billion
  • Q2 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$7.06 - $11.57 $3.96 Million - $6.48 Million
-560,444 Closed
0 $0
Q4 2021

Feb 10, 2022
SELL
$8.63 - $17.36 $81,389 - $163,722
-9,431 Reduced 1.65%
560,444 $5.65 Million
Q3 2021

Nov 12, 2021
BUY
$15.85 - $25.07 $9.03 Million - $14.3 Million
569,875 New
569,875 $9.03 Million

Others Institutions Holding NPCE

# of Institutions
52
Shares Held
21.3M
Call Options Held
1.3K
Put Options Held
100
View Full List

About NeuroPace Inc

NPCE Quotes by TradingView
  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $255M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email